Macuvision's AMD screening test launched worldwide
This article was originally published in Clinica
A screening test for age-related macular degeneration (AMD) can identify those at risk of the disease while they are still in their 20s. UK firm Macuvision Europe officially launches the test, called Macuscope, worldwide this week, having already installed several systems across Europe and North America.
You may also be interested in...
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.